Home › Funds › BlackRock Inc › MXCT
BlackRock Inc position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2026)3.06M sh
Reported value held$3.76M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 8.49M | $33.02M | New |
| Q4 2024 | 8.02M | $33.38M | Reduce |
| Q1 2025 | 8.17M | $22.30M | Add |
| Q1 2025 | 8.17M | $22.30M | Add |
| Q2 2025 | 10.20M | $22.24M | Add |
| Q2 2025 | 10.20M | $22.24M | Add |
| Q3 2025 | 9.98M | $15.77M | Reduce |
| Q4 2025 | 9.24M | $14.33M | Reduce |
| Q1 2026 | 8.80M | $6.18M | Reduce |
| Q2 2026 | 3.06M | $3.76M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026
- UBS Group AG 284.27K sh · $349.65K · Q2 2026